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Abstract
Emerging fungal and oomycete pathogens are increasingly threatening animals and plants
globally. Amongst oomycetes, Saprolegnia species adversely affect wild and cultivated
populations of amphibians and fish, leading to substantial reductions in biodiversity and
food productivity. With the ban of several chemical control measures, new sustainable
methods are needed to mitigate Saprolegnia infections in aquaculture. Here, PhyloChip-
based community analyses showed that the Pseudomonadales, particularly Pseudomonas
species, represent one of the largest bacterial orders associated with salmon eggs from a
commercial hatchery. Among the Pseudomonas species isolated from salmon eggs,
significantly more biosurfactant producers were retrieved from healthy salmon eggs than
from Saprolegnia-infected eggs. Subsequent in vivo activity bioassays showed that Pseu-
domonas isolate H6 significantly reduced salmon egg mortality caused by Saprolegnia
diclina. Live colony mass spectrometry showed that strain H6 produces a viscosin-like
lipopeptide surfactant. This biosurfactant inhibited growth of Saprolegnia in vitro, but no sig-
nificant protection of salmon eggs against Saprolegniosis was observed. These results indi-
cate that live inocula of aquatic Pseudomonas strains, instead of their bioactive compound,
can provide new (micro)biological and sustainable means to mitigate oomycete diseases in
aquaculture.
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Introduction
Emerging fungal and fungal-like diseases are causing severe ecological disruptions and are rec-
ognised as a global threat to biodiversity and food security [1, 2]. For example, Fusarium solani
is involved in mass mortality of eggs of the endangered sea turtles in Cape Verde [3], and
Batrachochytrium dendrobatidis and B. salmandrivorans are causing major amphibian declines
globally [4, 5]. Amongst oomycetes, Aphanomyces and Saprolegnia species are causing signifi-
cant declines in crayfish, fish and amphibian populations [1, 6–11]. Saprolegnia species are the
causative agents of Saprolegniosis, a disease characterized by fluffy and filamentous white or
grey mycelial patches on fish, fish eggs or amphibians [11]. In aquaculture, Saprolegnia species
regularly infect freshwater cultured salmonids, including Atlantic salmon and rainbow trout,
and non-salmonids like eel, perch, carp and catfish [7, 12]. In Japan, at least 50% annual mor-
tality in Coho salmon due to Saprolegniosis was reported [7, 13, 14]. Also the ‘winter kill’ by
Saprolegnia species in channel catfish in the USA resulted in a substantial financial loss of
approximately $40 million [7].
Formalin is now commonly used to control Saprolegniosis, but is expected to be banned
soon due to adverse environmental effects [7]. Several treatments have been tested to prevent
Saprolegniosis, such as hydrogen cyanide, Pyceze (bronopol), sea water flushes and NaCl, but
none of these measures exerted control to a level similar as obtained with malachite green, a
chemical banned due to its carcinogenic properties [7]. Currently, no vaccination is available
for Saprolegniosis [8]. Therefore, new sustainable measures are urgently needed. A potential
approach to control Saprolegniosis and other emerging diseases involves the application of
beneficial microbes. A limited number of bacterial genera and species, including Aeromonas
and Pseudomonas, have been reported as potential anti-pathogen agents in aquaculture, but a
comprehensive understanding of the microbiome composition of fish eggs and their protective
potential is still limited [15–21].
In previous work, we detected 31,281 bacterial and archaeal operational taxonomic units
(OTUs) on salmon eggs from a hatchery by PhyloChip metataxonomic analysis. The highest
number of OTUs belonged to Proteobacteria [22]. Based on this large-scale metataxonomic
analysis, the diversity of salmon egg-associated Proteobacteria and their functional potential to
protect fish eggs against Saprolegnia were investigated in this study. We focused specifically on
the Pseudomonadales and isolated several Pseudomonas strains, assessed their genotypic diver-
sity and tested their inhibitory activity against Saprolegnia species both in vitro and in vivo.
Given the zoosporicidal activity of biosurfactants produced by Pseudomonas species [23–25],
the isolates obtained from salmon eggs were also phenotypically screened for biosurfactant
production. For the Pseudomonas isolate that provided the best protection against Saprolegnio-
sis on salmon eggs, chemical profiling was performed by Nanospray Desorption ElectroSpray
Ionization (NanoDESI) live colony mass spectrometry followed by MS/MS analysis for partial
identification of the biosurfactant.
Materials and Methods
Isolation of bacteria associated with salmon eggs
Healthy and Saprolegnia-infected salmon eggs (N = 6 for healthy and N = 6 for diseased eggs)
and their corresponding incubation water was collected from a commercial hatchery [22]. To
release bacteria from the surface of eggs, approximately 30 eggs and 20 ml of incubation water
of each sample was transferred into a glass tube, vortexed for one minute, sonicated for one
minute and vortexed again for one minute. The total culturable bacteria were isolated and
enumerated by plating on 1/10th strength tryptone soya broth (Oxoid) with 15–20 gl-1 agar
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(1/10TSA) supplemented with 100 μg ml-1 Delvocid (DSM, Delft, Netherlands) to inhibit fun-
gal growth. Pseudomonas strains were isolated and enumerated on semi-selective Pseudomonas
agar F (PSA, Difco) supplemented with 100 μg ml-1 Delvocid, 12.5 μg ml-1 chloramphenicol
and 50 μg ml-1 ampicillin. Both media were incubated at 25°C for 4 days. From each replicate
sample and each growth medium, approximately 40 bacterial isolates were randomly selected
and stored, which resulted in a total of approximately 900 random bacterial isolates.
In vitro activity and biosurfactant production by the bacterial isolates
All bacterial isolates were tested for activity against Saprolegnia diclina strain VS20 and Sapro-
legnia parasitica strain CBS 223.65 (C65) according to Liu et al. [22]. Bacteria were spot-inocu-
lated at the edge of plates of 1/5th strength potato dextrose broth (Difco) with 15–20 g l-1 agar
(1/5PDA) and incubated for 2–4 days at 25°C prior to inoculation of a plug of Saprolegnia in
the centre of a 1/5PDA plate. Hyphal growth inhibition was monitored for all bacterial isolates
during incubation for 4–5 days at 18°C. All bacterial isolates were also screened for biosurfac-
tant production by the drop collapse assay according to the method described by de Bruijn
et al. [23].
Identification and phylogeny of bacterial isolates
Pseudomonas isolates inhibiting Saprolegnia hyphal growth and/or producing biosurfactants
were subjected to BOX-PCR fingerprinting using primer BOX A1R [26, 27]. Representative
isolates from the BOX groups with at least 4 isolates for diseased or for healthy salmon egg
samples were chosen for phylogenetic analysis. Therefore, a total of 27 representative isolates
(S1 Table) were selected and identified by 16S rRNA sequencing. Phylogenetic analyses,
including the 16S rRNA sequences of 29 known reference strains [28], was performed accord-
ing to Liu et al. [22]. The evolutionary distances were calculated using the Kimura 2-parameter
method [29].
In vivo bioassays to test disease suppression by Proteobacteria
The representative isolates were chosen for activity testing in salmon egg bioassays (S1 Table).
From the shared representative isolates, Pseudomonas isolates S1 and S2, which belonged to
the largest shared BOX group and originated from both healthy and diseased salmon eggs were
selected. Collectively, a total of 11 representative isolates were selected for activity testing in
salmon egg bioassays (S1 Table).
The experimental set-up of the in vivo bioassays was similar to that described by Liu et al.
[22]. For bioassay 1 conducted in Norway in 2012, salmon eggs used in this bioassay were 385
degree-days at the day of shipment. Each treatment was conducted in a separate incubation
unit containing three perforated cups with 30 live salmon eggs per cup. The 11 representative
isolates described above were pre-grown on PSA for 2 days at 25°C, washed with sterile de-
mineralized water and added to each salmon egg incubation unit to a final cell density of 108
CFU ml-1. S. diclina 765F3 and bacteria were added to the incubation units with 2.5 litre of de-
chlorinated Norwegian tap water on day 0 (0 day post inoculation) and egg mortality was
scored on day 6 (6 days post inoculation, dpi) and expressed as a percentage of the total num-
ber of salmon eggs. To further study the activity spectrum of the Pseudomonas isolates, a simi-
lar experiment was conducted with S. parasitica 762F4 [22]. To check if the bacterial isolates
alone were pathogenic to salmon eggs, a similar bioassay as described above was conducted
with the bacterial inoculum only. Also here, the percentage of egg mortality was determined at
6 dpi.
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For bioassay 2 conducted in The Netherlands in 2014, the experimental design was adjusted
to monitor the disease progress over a longer period of time. Therefore, the salmon eggs were
‘younger’ than those in bioassay 1, i.e. 321 degree-days at the day of shipment. Each treatment
was conducted in two separate incubation units; each incubation unit contained three perfo-
rated cups with 51±2 live salmon eggs per cup. Spontaneous rifampicin resistant mutants of
the Pseudomonas isolates were generated to allow monitoring of their population dynamics.
The Pseudomonas isolates were added to each salmon egg incubation unit filled with 2 litres of
well water [22] to the final cell density of 107 CFU ml-1. S. diclina 1152F4 [22] was used in
bioassay 2. Salmon eggs not treated with the bacterial isolates or exposed to S. diclina only
served as the controls. The egg incubation water of each incubation unit was sampled on day 1,
day 4 (0 dpi) and day 24 (20 dpi) and dilution-plated on PSA+rifampicin to determine the
density of the introduced isolates in the water. Colonization of the applied Pseudomonas iso-
lates on the salmon egg surface was determined by rolling one to two eggs from each cup on
PSA+rifampicin at 0 and 20 dpi as described by Liu et al. [22]. The percentage of salmon eggs
to which hyphae of S. diclina were attached was determined at 20 dpi according to Liu et al.
[22].
S. diclina 765F3 from the healthy sample and S. diclina 1152F4 from the diseased sample
were used as pathogen source in the bioassay 1 in 2012 and bioassay 2 in 2014, respectively.
These two S. diclina isolates showed similar pathogenicity on salmon eggs in 2012 [22].
Nucleotide sequence accession numbers
The 16S rRNA sequences of Pseudomonas strains D1, D2, D3, S1, S2, H1, H2, H3, H4, H5, H6
and S3-S18 have been deposited in GenBank under accession numbers KP890304-KP890314
and KT223371-KT223386, respectively.
Live colony NanoDESI MS/MS data acquisition and molecular
networking
The most antagonistic Pseudomonas isolate H6 was subjected to chemical profiling by Nanos-
pray Desorption ElectroSpray Ionization (NanoDESI) live colony mass spectrometry as
described previously [30, 31]. P. fluorescens SS101 and P. fluorescens SBW25 [30] were used as
references. Pseudomonas strains were cultured in Luria-Bertani broth by shaking overnight at
28°C. For PseudomonasH6, four cultures (0.5 μl each) were spot-inoculated on ISP2 agar
and incubated for 48 hours at 30°C [30]. P. fluorescens SS101 and P. fluorescens SBW25 were
streaked on 1/5th strength NBY agar (1 gl-1 glucose, 1.6 gl-1 nutrient broth, 0.4 gl-1 yeast extract
and 15 gl-1 agar) and cultured for 48 hours at 25°C. Data collection with a data-dependent MS/
MS method was conducted on a hybrid 6.4T LTQ-FT (Thermo Electron) mass spectrometer
according to Nguyen et al. [30].
The MS/MS data of strains PseudomonasH6, P. fluorescens SS101 and P. fluorescens SBW25
were combined with data obtained by Nguyen et al. (2013) [30] for 18 other Pseudomonads
and 42 Bacilli. Metabolic networks were generated by clustering as described previously [32]
using the GNPS website (http://gnps.ucsd.edu/). Algorithms were the same as described by
Nguyen et al. [30]. Networks were visualized using Cytoscape (v 3.1.1). The two plugins used
for aiding data visualization and sequence tagging were described previously by Nguyen et al.
[30].
HPLC analysis
PseudomonasH6, P. fluorescens SS101 and P. fluorescens SBW25 were pre-grown on PSA for
3–6 days at 25°C. Extraction of biosurfactants was conducted according to De Souza et al. [24].
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After lyophilization, the biosurfactant was dissolved in Milli-Q water. Reversed-Phase High
Performance Liquid Chromatography (RP-HPLC) analysis was performed by injection of
100 μl sample on a Waters 996 HPLC equipped with a Symmetry C18 Column (100 Å, 5 μm,
3.9 mm X 150 mm, Waters) as described previously [33]. Samples were analysed at a flow rate
of 0.5 ml/min for 50 min in an isocratic mobile phase of 45:40:15 acetonitrile:methanol:Milli-Q
water with 0.1% (v/v) trifluoroacetic acid.
In vitro inhibitory activity of biosurfactants against Saprolegnia hyphal
growth
The biosurfactant of Pseudomonas H6 was tested for activity against hyphae of S. diclina
1152F4 and S. parasitica C65 by adding the biosurfactant to 1 ml 1/5th strength potato dextrose
broth (1/5PDB) in 24-well cell-culture plates (Greiner Bio-One, Kremsmünster, Austria) to
final concentrations of 15, 40, 100, 200 μg ml-1, respectively. The lipopeptide surfactant masse-
tolide A produced by P. fluorescens SS101 was used as a standard. An agar plug of pre-grown
S. diclina 1152F4 or S. parasitica C65 of approximately 0.2 cm2 was added to each well and
incubated at 25°C. Hyphal growth inhibition was scored after 3 days for S. diclina 1152F4 or
2 days for S. parasitica C65. Morphological abnormalities were monitored under an Olympus
SZX12 stereomicroscope and image capture was accomplished using a Zeiss AxioCamMRc
5 camera with Zeiss AxioVision software (AxioVs40 V 4.8.2.0). ImageJ 1.47v [34] was used to
measure the diameter of 10 hyphae in each treatment.
In vivo effects of biosurfactants on Saprolegniosis
The salmon eggs had been incubated at 0.92°C on average at AquaGen AS (Trondheim, Nor-
way) and their age was 135 degree-days at the day of shipment. The set-up of the salmon egg
bioassay was similar to that of bioassay 2 described above. The biosurfactants from Pseudomo-
nasH6 and SS101 were tested at concentrations of 15±3 μg ml-1 and 40±8 μg ml-1. Malachite
green (2.5±0.5 μg ml-1 (ppm)) was used as a chemical reference. All treatments were performed
with three separate incubation units (biological replicates), except for the treatments without
S. diclina 1152F4 where one incubation unit with three incubation cups (technical reps) was
used; each cup contained 51±2 live salmon eggs. Application of biosurfactants or malachite
green was conducted every 2–3 days by reducing the water level to 600±100 ml and exposing
the salmon eggs to the corresponding chemicals for 90–120 min with aeration. Afterwards, the
treated water was removed. Each incubation unit was rinsed by 100–200 ml fresh well water
and finally 2 litres of fresh well water was added. The percentage of hyphal attachment of
S. diclina to the salmon eggs was determined on 18 dpi.
Results and Discussion
PhyloChip-based community profiling
Previously we analysed the bacterial community compositions of healthy salmon eggs and
Saprolegnia-infected salmon eggs (referred to as diseased salmon eggs) by PhyloChip-based
profiling [22]. Healthy eggs harboured more OTUs belonging to the Proteobacteria than dis-
eased eggs [22]. Amongst the phylum Proteobacteria, the class Gammaproteobacteria was
most represented (Fig 1A). Within the Gammaproteobacteria, most OTUs belonged to the
orders Enterobacteriales and Pseudomonadales (Fig 1B), accounting for 6.57% and 6.71% of
the total bacterial OTUs detected on average on salmon eggs, respectively. The majority of
OTUs of the family Pseudomonadaceae belonged to Pseudomonas, representing 935 OTUs on
average. No significant differences were found in the number of Pseudomonas OTUs between
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diseased and healthy salmon eggs. Given that Pseudomonas species (Pseudomonadales) are
considered as potential aquaculture probiotics [35], a more in-depth analysis was conducted
here to unravel the genotypic and functional diversity of Pseudomonas species associated with
healthy and diseased salmon eggs (S1 Fig).
Isolation, in vitro activity and phylogeny of aquatic Pseudomonas
The bacteria attached to the salmon eggs were released by vortexing and sonication in the incu-
bation water from the hatchery. The total count of culturable aerobic bacteria was approxi-
mately 3X107 CFU ml-1 for both healthy and diseased salmon eggs (S2 Fig). Amongst 440
randomly selected isolates, 7% and 13% inhibited hyphal growth of Saprolegnia diclina VS20
and Saprolegnia parasitica C65, respectively. Drop collapse assays further revealed that 3% of
the 1/10TSA isolates produced biosurfactants under the experimental conditions tested. For
both the healthy and diseased salmon egg samples, the putative Pseudomonas population den-
sity enumerated on semi-selective PSA medium was approximately 106 CFU ml-1 (S2 Fig).
Amongst 465 randomly selected Pseudomonas isolates, 60–69% of the isolates from the dis-
eased salmon eggs and 72–80% of the isolates from the healthy salmon eggs inhibited hyphal
growth of S. diclina VS20 and/or S. parasitica C65. No statistically significant difference was
observed between diseased and healthy salmon eggs in the percentage of isolates with in vitro
growth-inhibiting activities (Fig 2A). However, based on the results obtained in drop collapse
assays, healthy eggs harboured a significantly higher frequency (64±7%) of biosurfactant-pro-
ducing Pseudomonas isolates than diseased salmon eggs (34±8%) (Fig 2B). A marine biosurfac-
tant-producing Lactobacillus pentosus provided protection for the crustacean Artemia against
pathogenic Vibrio alginolyticus, suggesting a potential role of biosurfactants in disease suppres-
sion [36].
Genotypic profiling by BOX-PCR of the Pseudomonas isolates that inhibited Saprolegnia
hyphal growth in vitro and/or produced biosurfactants, resulted in 131 BOX groups with 43
and 71 unique groups from diseased (D) or healthy (H) salmon egg samples, respectively, and
17 groups with isolates found in both diseased and healthy samples (referred to as ‘shared’ iso-
lates (S)) (Fig 2C). Representative isolates from BOX groups that consisted of at least 4 isolates
Fig 1. Proteobacteria (A) and Gammaproteobacteria (B) community analyses of diseased and healthy
salmon eggs by PhyloChip-based analyses. Salmon eggs were sampled from a commercial hatchery [22].
Indicated is the average number of OTUs at different taxonomic levels: the phylum Proteobacteria (A) and the
class Gammaproteobacteria (B). Error bars represent S.E.M. (N = 6).
doi:10.1371/journal.pone.0136241.g001
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unique for diseased (D) or healthy (H) samples, as well as 18 isolates from the 9 ‘shared’ (S)
BOX groups (S1 Table) were subjected to phylogenetic analyses. No distinct differences were
observed in the 16S rRNA-based phylogenetic delineation of Pseudomonas isolates from dis-
eased or healthy salmon eggs. Most of the isolates belonged to the P. fluorescens clade, includ-
ing the isolates from the shared BOX groups, except isolate S13 and S14 that clustered with
P. syringae (Fig 3).
Bioactivity of aquatic Pseudomonas in vivo
When Pseudomonas isolates were applied at an initial density of 107 CFU ml-1 to the incuba-
tion water in vivo, seven out of eleven Pseudomonas isolates significantly reduced hyphal
attachment of S. diclina to salmon eggs (Fig 4). Strains originally isolated from healthy salmon
Fig 2. Phenotypic and genotypic analysis of Pseudomonas isolates. The isolates were obtained from
healthy salmon egg samples and salmon eggs infected with Saprolegnia. (A) Mean percentage of the number
of bacterial isolates that were inhibitory to hyphal growth of Saprolegnia diclina VS20 and Saprolegnia
parasitica CBS 223.65, tested by observation of an inhibition halo around the bacterial colony (right panel
insert). (B) Mean percentage of the number of bacterial isolates that produce biosurfactants based on the
drop collapse assay (right panel insert). Error bars represent the S.E.M. (N = 6). The asterisk indicates a
statistically significant difference (P<0.05, Student’s t-test). (C) Genotypic BOX-PCR grouping of bacterial
isolates that inhibiting Saprolegnia hyphal growth and/or producing biosurfactants. The Venn diagram (left
panel insert) shows the total number of BOX groups obtained for isolates from either diseased, healthy or
both samples. An example of the DNA profiles obtained by BOX-PCR is shown in agarose gel (right panel
insert).
doi:10.1371/journal.pone.0136241.g002
Anti-Oomycete Activity of Aquatic Pseudomonas
PLOSONE | DOI:10.1371/journal.pone.0136241 August 28, 2015 7 / 17
Fig 3. Phylogenetic tree of 16S rRNA sequences of Pseudomonas strains representative of 18
BOX-PCR groups. The 16S rRNA sequences were approximately 960 bp. The BOX-PCR groups were
identified among the Pseudomonas isolates from healthy and diseased salmon eggs (S1 Table). A total of 29
reference Pseudomonas species/strains were included to delineate the 27 aquatic Pseudomonas strains
obtained in this study. Bootstrap values at the nodes are based on 1000 replications. Only those branch
values higher than 80% are shown. Asterisks indicate the isolates selected for salmon egg bioassays.
doi:10.1371/journal.pone.0136241.g003
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egg samples showed a better control efficacy than those originally isolated from diseased
salmon egg samples (Fig 4), suggesting that the healthy salmon eggs harbour Pseudomonas
strains with stronger activity against Saprolegnia. The bacterial density in the incubation water
decreased from 106−107 CFU ml-1 on 0 dpi to 103−105 CFU ml-1 on 20 dpi. When tested
against another S. diclina isolate and S. parasitica isolate under different temperatures and
bacterial densities, only Pseudomonas strain H6 showed the most consistent activity against
Saprolegnia in all cases (S3 and S4A Figs). Hence, strain H6 was selected for further
characterization.
Chemical profiling of aquatic Pseudomonas strain H6
To elucidate which compounds Pseudomonas strain H6 produces, live colony mass spectrome-
try and MS/MS analyses were performed with two phylogenetically related strains P. fluores-
cens SS101 and SBW25 as references. A Cytoscape network with spectra of in total 21
Pseudomonads and 42 Bacilli strains [30] showed that PseudomonasH6 produces a predomi-
nant compound with a parent mass-to-charge ratio ofm/z 1148.65, which clustered together
with the lipopeptides massetolide A (m/z 1162.69) and viscosin (m/z 1148.67) produced by
strains SS101 and SBW25, respectively (Fig 5A). Further examination of the raw MS/MS data
showed that mass shifts could be linked to specific amino acids, which created identical
sequence tags of 87-113-87-113 Da (Ser-Leu/Ile-Ser-Leu/Ile) for the lipopeptide surfactants
produced by PseudomonasH6, P. fluorescens SS101 and SBW25 (Fig 5B) [30]. These results
suggest that PseudomonasH6 produces a lipopeptide surfactant with a peptide moiety that is,
most likely, structurally similar to that of massetolide A and viscosin. RP-HPLC analysis of the
lipopeptide surfactants extracted from these three strains revealed a difference in retention
time of the biosurfactants from PseudomonasH6, P. fluorescens SS101 and SBW25 (Fig 5C),
suggesting that the lipopeptide biosurfactant produced by PseudomonasH6 is structurally not
identical to massetolide A or viscosin. The small shift in retention could also be due to a struc-
tural difference in the lipid moiety.
Fig 4. In vivo activity of 11 Pseudomonas strains against S. diclina 1152F4. In bioassay 2, the mean
percentage of eggs to which of S. diclina 1152F4 hyphae attached was determined at 20 days post
inoculation (dpi) [22]. Bacterial strains were introduced at an initial cell density of 107 CFUml-1. The
incubation temperature was 5–7°C. Error bars represent S.E.M. (N = 6). Asterisks indicate statistically
significant differences with the control, S. diclina only, based on a one-way analysis of variance and post hoc
LSD analysis (P<0.05).
doi:10.1371/journal.pone.0136241.g004
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Activity profiling of lipopeptide surfactant from aquatic Pseudomonas
strain H6
We tested the effect of the purified lipopeptide surfactants of PseudomonasH6 and P. fluores-
cens SS101 on hyphal growth of S. diclina 1152F4 (Fig 6A). Both surfactants showed growth-
inhibitory activity at 15 μg ml-1, the lowest concentration tested. Hyphal growth was almost
completely inhibited at 100 μg ml-1 for the biosurfactant of PseudomonasH6 and at 200 μg
ml-1 for massetolide A of P. fluorescens SS101 (Fig 6A). The biosurfactant of H6 also showed a
Fig 5. Live colonymass spectrometry and MS/MS networking. (A) Molecular network of PseudomonasH6, P. fluorescensSS101, P. fluorescensSBW25
and 18 other Pseudomonads and 42 Bacilli [30]. The viscosin-like cluster was boxed and enlarged. (B) Selection of nodes of PseudomonasH6, P. fluorescens
SS101 and SBW25 for MS/MS raw spectra analyses and generation of amino acid sequence tag. The sequence tag is created by analysing the mass shifts
between adjacent ions in the MS/MS spectra, which are corresponding to the mass of an amino acid. The value of the parent mass ions for PseudomonasH6
and P. fluorescens SBW25 in Fig 5B is not completely matching to the parent mass ion as indicated in Fig 5A, because during network analyses a mass
tolerance setting of 0.3 Da was used. (C) Reversed-phase HPLC chromatograms of cell-free culture extracts of lipopeptide surfactants from PseudomonasH6,
P. fluorescens SS101 and SBW25.
doi:10.1371/journal.pone.0136241.g005
Anti-Oomycete Activity of Aquatic Pseudomonas
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stronger activity compared to massetolide A against hyphal growth of S. parasitica (Fig 7A).
Lipopeptide surfactants are known to cause hyphal swelling, hyphal branching, zoospore lysis
and inhibition of cyst germination of plant pathogenic oomycetes [23, 37, 38]. When we inves-
tigated the effect of the lipopeptide surfactants of strains H6 and SS101 microscopically, the
diameter of S. parasitica hyphae grown in the presence of biosurfactants was larger (S2 Table)
and exhibited a higher number of branches compared to the control. This phenotypic effect
intensified with increasing biosurfactant concentrations; furthermore, massetolide A induces
more hyphal branching than the PseudomonasH6 biosurfactant (Fig 7B).
The lipopeptide surfactants from PseudomonasH6 and P. fluorescens SS101 were tested in
an in vivo bioassay at concentrations of 15±3 μg ml-1 and 40±8 μg ml-1 of incubation water.
Because the set-up of the in vivo bioassays involved large volumes and the yield of biosurfac-
tants was relatively low, higher biosurfactant concentrations were not tested. At the concentra-
tions tested, no significant reductions in attachment of S. diclina hyphae to salmon eggs were
found, whereas the chemical control (malachite green) did significantly reduce hyphal attach-
ment (Fig 6B). Although the lipopeptide surfactants were applied every 2–3 days for a duration
of 90–120 min each time, instability (e.g. degradation) and/or a too short exposure time may
have caused a lack of in vivo activity. Biosurfactants have been shown to be degraded in aquatic
systems and non-sterile soil [39–41] and the same may have occurred in the salmon egg
Fig 6. Effect of biosurfactants fromPseudomonasH6 and P. fluorescens SS101 on S. diclina 1152F4. (A)
S. diclina 1152F4 hyphal plugs were incubated for 3 days in 1/5PDB supplemented with biosurfactants from
PseudomonasH6 or P. fluorescens SS101 (massetolide A) at concentrations ranging from 15 to 200 μg ml-1.
(B) The activity of the biosurfactants against S. diclina under in vivo condition was assessed by determining the
mean percentage of salmon eggs to which S. diclina 1152F4 hyphae were attached at 18 dpi. Salmon eggs
were treated with biosurfactants from PseudomonasH6 and P. fluorescens SS101 at 15±3 μg ml-1 and 40±8 μg
ml-1. Eggs exposed to S. diclina only were used as negative control. Eggs treated with 2.5±0.5 μg ml-1 (ppm)
malachite green and S. diclinawere used as the chemical reference. Error bars represent S.E.M. (N = 9). The
asterisk indicates a statistically significant difference from the negative control (S. diclina only) based on one-
way analysis of variance and post hoc LSD analysis (P<0.05).
doi:10.1371/journal.pone.0136241.g006
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incubation units. The fate of the biosurfactants could not be analysed by RP-HPLC analysis,
since the applied concentrations were below the detection limit. Although the biosurfactants
alone did not affect hyphal attachment by Saprolegnia in vivo, this does not exclude that these
compounds may play a role in the activity of the producing bacterial strain, an aspect that
remains to be further investigated. Lipopeptide surfactants are well-known for their role in bio-
film formation [23, 37] and may have enabled PseudomonasH6 to colonize the salmon egg sur-
face to form a protective biofilm that avoids hyphal attachment by Saprolegnia. Also the
biosurfactant produced by Lactobacillus pentosus was suggested to facilitate the adhesion to the
Fig 7. Effect of biosurfactants from Pseudomonas H6 and P. fluorescens SS101 on S. parasitica CBS 223.65. The effect was according to hyphal
growth (A) and hyphal morphology (B). S. parasitica hyphal plugs were grown for 48 hours in 1/5PDB supplemented with biosurfactants from Pseudomonas
H6 or P. fluorescens SS101 (massetolide A) at concentrations ranging from 15 to 200 μg ml-1. The bottom row shows the enlargement of the area indicated in
the top row. White arrows indicate branching hyphae. The scale bars in the pictures of panel B represent 100 μm.
doi:10.1371/journal.pone.0136241.g007
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Artemia gut, thereby excluding the colonization of pathogenic Vibrio alginolyticus [36]. The
bacterial biofilm provides an ecological niche in which the bacterial cells produce a protective
extracellular matrix that is beneficial to their growth and development by excluding other
microbes [35]. Whether the biosurfactants are actually produced in the egg incubation units or
on the egg surfaces by the introduced Pseudomonas strains is not known. Recently, Song and
colleagues [42] showed that massetolide A production by P. fluorescens SS101 increased at
lower temperatures, indicating that the low temperatures (5–10°C) used in the salmon egg
assays may be favourable for biosurfactant production. To provide more evidence for a role of
the lipopeptide surfactant of PseudomonasH6 in in situ production and protection against
Saprolegniosis, site-directed mutagenesis of the biosynthetic genes should be performed in
future studies, followed by in vivo bioassays where gene transcriptional analyses are conducted
and activities of surfactant-deficient mutants are compared to those of the wild type strain H6.
Additionally, even though P. fluorescens is recognized as a beneficial microbe against Saproleg-
nia [20], is it also known to be pathogenic to a wide range of fish species, mostly to carps [43]
but also to salmonids like rainbow trout (Oncorhynchus mykiss) [43] and Chinook salmon
(Oncorhynchus tshawytscha) [44]. For some of the Pseudomonas isolates tested here, except
H6, we indeed observed adverse effects on the salmon eggs (S4B Fig). Further studies should
also look into effects of P. fluorescens H6 on the life-cycle of salmon post hatching.
Conclusions
Aquaculture is one of the fastest growing animal food sectors [45], partly as a response to the
increasing demand for fish protein and regulations to prevent overfishing from wild popula-
tions [7]. Considering the long-term importance of aquaculture for food production and eco-
nomic development, sustainable measures are urgently needed to mitigate emerging diseases
including Saprolegniosis. Although the biosurfactant from PseudomonasH6 did not show
activity in vivo, the bacterial strain itself did provide promising antagonistic activity against
Saprolegnia infections of salmon eggs. Our research provides a framework for selecting benefi-
cial bacteria that can suppress Saprolegniosis and possibly other emerging diseases in
aquaculture.
Supporting Information
S1 Fig. Overall strategy used to decipher diversity of aquatic Pseudomonas species and their
activity against the fish pathogenic oomycete Saprolegnia.
(TIF)
S2 Fig. Colony count of salmon egg incubation water dilution-plated on 1/10TSA and PSA.
Error bars represent S.E.M. (N = 6).
(TIF)
S3 Fig. In vivo activity of the 11 aquatic Pseudomonas strains against S. diclina on salmon
eggs. The mean percentage of egg mortality caused by S. diclina 765F3 was determined at 6
days post inoculation (dpi) of this oomycete pathogen. Pseudomonas strains D1-D3 and S1
originated from diseased salmon eggs, whereas strains S2 and H1-H6 originated from healthy
salmon eggs. All strains were introduced at an initial cell density of 108 CFU ml-1. The incuba-
tion temperature was 10±1°C. Error bars represent S.E.M. (N = 3). The asterisk indicates a sta-
tistically significant difference from the control (S. diclina only) based on a one-way analysis of
variance and post hoc LSD analysis (P<0.05).
(TIF)
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S4 Fig. In vivo activity of 11 Pseudomonas isolates against S. parasitica and their effect on
salmon egg mortality. In bioassay 1, the initial bacterial density was 108 CFU ml-1 and incuba-
tion temperature was 10±1°C. (A) Mean percentage of egg mortality was determined at 6 dpi
of S. parasitica 762F4 [22]. PseudomonasH6 reduced (P = 0.062) mortality compared to the
control with S. parasitica only. (B) Mean percentage of egg mortality inoculated with cell sus-
pensions of 11 Pseudomonas strains only. Error bars represent S.E.M. (N = 3). Asterisks indi-
cate statistically significant differences from the controls, S. parasitica only (A) or non-treated
(B) based on one-way analysis of variance and post hoc LSD analysis on ArcSin square root
transformed data (P<0.05).
(TIF)
S1 Table. BOX-PCR genotypic grouping of bacteria isolated from diseased and healthy
salmon eggs by plating incubation water on the Pseudomonas semi-selective medium PSA.
Only the BOX groups that consisted of at least 4 isolates from either diseased or healthy salmon
egg samples are shown. One representative isolate from each BOX group was selected for activ-
ity testing in salmon egg bioassays. From the shared representative isolates, Pseudomonas iso-
lates S1 and S2, which belonged to the largest shared BOX group and originated from both
healthy and diseased salmon eggs were selected.a Isolates H3 and S2 were obtained from 1/
10TSA, not from PSA.
(PDF)
S2 Table. Effect of biosurfactants from PseudomonasH6 and P. fluorescens SS101 on
hyphal diameter of S. parasitica CBS 223.65. Diameter of 10 S. parasitica hyphae of each
treatment was measured by ImageJ 1.47v. Mean diameter and standard error of the mean are
shown. Asterisks indicate statistically significant differences compared to the controls, based
on a one-way analysis of variance and post hoc LSD analysis (P<0.05).
(PDF)
Acknowledgments
We appreciate the help and valuable advices fromMenno ter Veld and Geert Wiegertjes (Ani-
mal Sciences, Wageningen University, The Netherlands) for the in vivo experiments. This
manuscript is publication number 5912 of Netherlands Institute of Ecology (NIOO-KNAW).
Author Contributions
Conceived and designed the experiments: YL ER IdB MvdV VB JMR. Performed the experi-
ments: YL ER MvdV CHW ET. Analyzed the data: YL ER CHWMvdV IdB. Wrote the paper:
YL ER IdB MvdV VB JMR. Performed the strain isolations and characterization, genomic fin-
gerprinting, phylogenetic analyses, in vitro and in vivo experiments: YL. Performed tests of
massetolide A against S. parasitica: YL ER. Performed live colony mass spectrometry analysis:
MvdV CHW PCD. Created figures: YL ER CHWMvdV IdB. Contributed to HPLC analysis:
MvdV. Contributed to design of bioassays: ET IS. Contributed to performance of bioassays:
ET. Contributed to review of the manuscript: all authors.
References
1. Fisher MC, Henk DA, Briggs CJ, Brownstein JS, Madoff LC, McCraw SL, et al. Emerging fungal threats
to animal, plant and ecosystem health. Nature. 2012; 484(7393):186–94. http://www.nature.com/
nature/journal/v484/n7393/abs/nature10947.html#supplementary-information. doi: 10.1038/
nature10947 PMID: 22498624
Anti-Oomycete Activity of Aquatic Pseudomonas
PLOSONE | DOI:10.1371/journal.pone.0136241 August 28, 2015 14 / 17
2. Gozlan RE, Marshall W, Lilje O, Jessop C, Gleason FH, Andreou D. Current ecological understanding
of fungal-like pathogens of fish: what lies beneath? Frontiers in Microbiology. 2014; 5. doi: 10.3389/
fmicb.2014.00062
3. Sarmiento-Ramírez JM, Abella-Pérez E, Phillott AD, Sim J, vanWest P, Martín MP, et al. Global Distri-
bution of Two Fungal Pathogens Threatening Endangered Sea Turtles. PLoS ONE. 2014; 9(1):
e85853. doi: 10.1371/journal.pone.0085853 PMID: 24465748
4. Martel A, Spitzen-van der Sluijs A, Blooi M, Bert W, Ducatelle R, Fisher MC, et al. Batrachochytrium sal-
amandrivorans sp. nov. causes lethal chytridiomycosis in amphibians. Proceedings of the National
Academy of Sciences of the United States of America. 2013; 110(38):15325–9. doi: 10.1073/pnas.
1307356110 PMID: WOS:000324495300049.
5. Woodhams DC, Bosch J, Briggs CJ, Cashins S, Davis LR, Lauer A, et al. Mitigating amphibian disease:
strategies to maintain wild populations and control chytridiomycosis. Frontiers in Zoology. 2011; 8. doi:
10.1186/1742-9994-8-8 PMID: WOS:000290856400001.
6. Phillips AJ, Anderson VL, Robertson EJ, Secombes CJ, vanWest P. New insights into animal patho-
genic oomycetes. Trends in Microbiology. 2008; 16(1):13–9. doi: http://dx.doi.org/10.1016/j.tim.2007.
10.013 PMID: 18096392
7. Bruno D, vanWest P, Beakes G. Saprolegnia and other oomycetes. In: Woo P, Bruno D, editors. Fish
Diseases and Disorders, Viral, Bacterial and Fungal Infections. 3. 2nd ed. Wallingford, UK: CABI:
Wallingford, UK; 2011. p. 669–720.
8. van den Berg AH, McLaggan D, Diéguez-Uribeondo J, vanWest P. The impact of the water moulds
Saprolegnia diclina and Saprolegnia parasitica on natural ecosystems and the aquaculture industry.
Fungal Biology Reviews. 2013; 27(2):33–42. doi: http://dx.doi.org/10.1016/j.fbr.2013.05.001
9. Fernández-Benéitez MJ, Ortiz-Santaliestra ME, Lizana M, Diéguez-Uribeondo J. Saprolegnia diclina:
another species responsible for the emergent disease ‘Saprolegnia infections’ in amphibians. FEMS
Microbiology Letters. 2008; 279(1):23–9. doi: 10.1111/j.1574-6968.2007.01002.x PMID: 18177304
10. Krugner-Higby L, Haak D, Johnson P, Shields J, JonesWI, Reece K, et al. Ulcerative disease outbreak
in crayfishOrconectes propinquus linked to Saprolegnia australis in Big Muskellunge Lake, Wisconsin.
Diseases of Aquatic Organisms. 2010; 91(1):57–66. doi: 10.3354/dao02237 PMID: 20853742
11. vanWest P. Saprolegnia parasitica, an oomycete pathogen with a fishy appetite: new challenges for an
old problem. Mycologist. 2006; 20(3):99–104. doi: http://dx.doi.org/10.1016/j.mycol.2006.06.004
12. Das SK, Murmu K, Das A, Shakuntala I, Das RK, Ngachan SV, et al. Studies on the identification and
control of pathogen Saprolegnia in selected Indian major carp fingerlings at mid hill altitude. Journal of
environmental biology / Academy of Environmental Biology, India. 2012; 33(3):545–9. Epub 2012/10/
04. PMID: 23029901.
13. Hatai K, Hoshiai G. Mass mortality in cultured coho salmon (Oncorhynchus kisutch) due to Saprolegnia
parasitica coker. Journal of Wildlife Diseases. 1992; 28(4):532–6. doi: 10.7589/0090-3558-28.4.532
PMID: 1474649
14. Hatai K, Hoshiai G-I. Pathogenicity of Saprolegnia parasitica Coker. In: Mueller GJ, editor. Salmon
Saprolegniasis. Portland, Oregon: U.S. Department of Energy, Bonneville Power Administration, Port-
land, Oregon; 1994.
15. Lategan MJ, Gibson LF. Antagonistic activity of Aeromonas media strain A199 against Saprolegnia sp.,
an opportunistic pathogen of the eel, Anguilla australisRichardson. Journal of Fish Diseases. 2003; 26
(3):147–53. doi: 10.1046/j.1365-2761.2003.00443.x PMID: WOS:000181372700003.
16. Lategan MJ, Torpy FR, Gibson LF. Biocontrol of saprolegniosis in silver perch Bidyanus bidyanus
(Mitchell) by Aeromonas media strain A199. Aquaculture. 2004; 235(1–4):77–88. doi: 10.1016/j.
aquaculture.2003.09.014 PMID: WOS:000221547500007.
17. Lategan MJ, Torpy FR, Gibson LF. Control of saprolegniosis in the eel Anguilla australis Richardson, by
Aeromonas media strain A199. Aquaculture. 2004; 240(1–4):19–27. doi: 10.1016/j.aquaculture.2004.
04.009 PMID: WOS:000224814900002.
18. Hatai K, Willoughby LG. Saprolegnia parasitica from rainbow trout inhibited by the bacterium Pseudo-
monas fluorescens. Bull Eur Ass Fish Pathol. 1988; 8(2):27–9.
19. Hussein MMA, Hatai K. In vitro inhibition of Saprolegnia by bacteria isolated from lesions of salmonids
with saprolegniasis. Fish Pathology. 2001; 36(2):73–8. PMID: WOS:000169441400004.
20. Bly JE, Quiniou SMA, Lawson LA, Clem LW. Inhibition of Saprolegnia pathogenic for fish by Pseudo-
monas fluorescens. Journal of Fish Diseases. 1997; 20(1):35–40. doi: 10.1046/j.1365-2761.1997.d01-
104.x PMID: WOS:A1997WB58100005.
21. Carbajal-González MT, Fregeneda-Grandes JM, Suárez-Ramos S, Rodríguez-Cadenas F, Aller-Gan-
cedo JM. Bacterial skin flora variation and in vitro inhibitory activity against Saprolegnia parasitica in
Anti-Oomycete Activity of Aquatic Pseudomonas
PLOSONE | DOI:10.1371/journal.pone.0136241 August 28, 2015 15 / 17
brown and rainbow trout. Diseases of Aquatic Organisms. 2011; 96(2):125–35. doi: 10.3354/dao02391
PMID: WOS:000294732900005.
22. Liu Y, de Bruijn I, Jack ALH, Drynan K, van den Berg AH, Thoen E, et al. Deciphering microbial land-
scapes of fish eggs to mitigate emerging diseases. ISME J. 2014; 8(10):2002–14. doi: 10.1038/ismej.
2014.44 PMID: 24671087
23. de Bruijn I, de Kock MJD, Yang M, de Waard P, van Beek TA, Raaijmakers JM. Genome-based discov-
ery, structure prediction and functional analysis of cyclic lipopeptide antibiotics in Pseudomonas spe-
cies. Molecular Microbiology. 2007; 63(2):417–28. doi: 10.1111/j.1365-2958.2006.05525.x PMID:
17241198
24. De Souza JT, De Boer M, DeWaard P, Van Beek TA, Raaijmakers JM. Biochemical, genetic, and zoos-
poricidal properties of cyclic lipopeptide surfactants produced by Pseudomonas fluorescens. Applied
and environmental microbiology. 2003; 69(12):7161–72. Epub 2003/12/09. PMID: 14660362; PubMed
Central PMCID: PMCPmc309978.
25. Raaijmakers JM, de Bruijn I, de Kock MJD. Cyclic lipopeptide production by plant-associated Pseudo-
monas spp.: diversity, activity, biosynthesis, and regulation. Molecular Plant-Microbe Interactions.
2006; 19(7):699–710. doi: 10.1094/MPMI-19-0699 PMID: 16838783
26. Rademaker JLW, Louws FJ, de Bruijn FJ. Characterization of the diversity of ecologically important
microbes by rep-PCR genomic fingerprinting. In: Akkermans ADL, van Elsas JD, de Bruijn FJ, editors.
Molecular Microbial Ecology Manual. Dordrecht: Kluwer; 1998. p. 1–26.
27. Versalovic J, Schneider M, de Bruijn FJ, Lupski JR. Genomic fingerprinting of bacteria using repetitive
sequence based PCR (rep-PCR). Meth Cell Mol Biol. 1994; 5:25–40.
28. Loper JE, Hassan KA, Mavrodi DV, Davis EW II, Lim CK, Shaffer BT, et al. Comparative genomics of
plant-associated Pseudomonas spp.: insights into diversity and inheritance of traits involved in multi-
trophic interactions. PLoS Genet. 2012; 8(7):e1002784. doi: 10.1371/journal.pgen.1002784 PMID:
22792073
29. Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative
studies of nucleotide sequences. J Mol Evol. 1980; 16(2):111–20. Epub 1980/12/01. PMID: 7463489.
30. Nguyen DD, Wu C-H, MoreeWJ, Lamsa A, MedemaMH, Zhao X, et al. MS/MS networking guided
analysis of molecule and gene cluster families. Proceedings of the National Academy of Sciences.
2013. doi: 10.1073/pnas.1303471110
31. Watrous J, Roach P, Alexandrov T, Heath BS, Yang JY, Kersten RD, et al. Mass spectral molecular
networking of living microbial colonies. Proceedings of the National Academy of Sciences. 2012. doi:
10.1073/pnas.1203689109
32. Pierce CY, Barr JR, Cody RB, Massung RF, Woolfitt AR, Moura H, et al. Ambient generation of fatty
acid methyl ester ions from bacterial whole cells by direct analysis in real time (DART) mass spectrome-
try. Chemical Communications. 2007;(8: ):807–9. doi: 10.1039/B613200F PMID: 17308638
33. Cheng X, van der Voort M, Raaijmakers JM. Gac-mediated changes in pyrroloquinoline quinone bio-
synthesis enhance the antimicrobial activity of Pseudomonas fluorescens SBW25. Environmental
Microbiology Reports. 2015:n/a-n/a. doi: 10.1111/1758-2229.12231
34. Schneider CA, RasbandWS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Meth.
2012; 9(7):671–5.
35. Verschuere L, Rombaut G, Sorgeloos P, Verstraete W. Probiotic bacteria as biological control agents in
aquaculture. Microbiology and Molecular Biology Reviews. 2000; 64(4):655–+. doi: 10.1128/mmbr.64.
4.655–671.2000 PMID: WOS:000167056400001.
36. Garces ME, Sequeiros C, Olivera NL. Marine Lactobacillus pentosusH16 protects Artemia franciscana
from Vibrio alginolyticus pathogenic effects. Diseases of Aquatic Organisms. 2015; 113(1):41–50. doi:
10.3354/dao02815 PMID: WOS:000349301900005.
37. de Bruijn I, de Kock MJD, deWaard P, van Beek TA, Raaijmakers JM. Massetolide a biosynthesis in
Pseudomonas fluorescens. Journal of Bacteriology. 2008; 190(8):2777–89. doi: 10.1128/jb.01563-07
PMID: WOS:000254773200015.
38. van de Mortel JE, Ha T, Govers F, Raaijmakers JM. Cellular Responses of the Late Blight Pathogen
Phytophthora infestans to Cyclic Lipopeptide Surfactants and Their Dependence on G Proteins.
Applied and environmental microbiology. 2009; 75(15):4950–7. doi: 10.1128/aem.00241-09 PMID:
WOS:000268311600003.
39. Nielsen TH, Sørensen J. Production of cyclic lipopeptides by Pseudomonas fluorescens strains in bulk
soil and in the sugar beet rhizosphere. Applied and environmental microbiology. 2003; 69(2):861–8.
doi: 10.1128/aem.69.2.861–868.2003 PMID: WOS:000180927100018.
40. Abd-Allah AMA, Srorr T. Biodegradation of anionic surfactants in the presence of organic contaminants.
Water Research. 1998; 32(3):944–7. doi: http://dx.doi.org/10.1016/S0043-1354(97)00223-6
Anti-Oomycete Activity of Aquatic Pseudomonas
PLOSONE | DOI:10.1371/journal.pone.0136241 August 28, 2015 16 / 17
41. Abu-Ghunmi L, Badawi M, Fayyad M. Fate of Triton X-100 Applications onWater and Soil Environ-
ments: A Review. J Surfact Deterg. 2014; 17(5):833–8. doi: 10.1007/s11743-014-1584-3
42. Song C, Aundy K, van de Mortel J, Raaijmakers JM. Discovery of new regulatory genes of lipopeptide
biosynthesis in Pseudomonas fluorescens. FEMSMicrobiology Letters. 2014; 356(2):166–75. doi: 10.
1111/1574-6968.12404 PMID: 25202778
43. Austin B, Austin DA. Bacterial fish pathogens: disease of farmed and wild fish: Springer Science &
Business Media; 2007.
44. Loch TP, Scribner K, Tempelman R, Whelan G, Faisal M. Bacterial infections of Chinook salmon,
Oncorhynchus tshawytscha (Walbaum), returning to gamete collecting weirs in Michigan. J Fish Dis.
2012; 35(1):39–50. Epub 2011/12/16. doi: 10.1111/j.1365-2761.2011.01322.x PMID: 22168454.
45. FAO. The state of world fisheries and aquaculture 2014. Rome, Italy2014. 223 p.
Anti-Oomycete Activity of Aquatic Pseudomonas
PLOSONE | DOI:10.1371/journal.pone.0136241 August 28, 2015 17 / 17
